Recall of Promacta 12.5mg for Oral Suspension
Novartis is voluntarily recalling 3 lots of Promacta 12.5mg for oral suspension distributed starting May 11, 2019. The Food and Drug Administration (FDA) classified this recall as a Class I Recall on May 29, 2019.
The maker is recalling Promacta 12.5mg for oral suspension because the product may have been contaminated with peanut flour.
We want you to get the information you need to take care of your health. Please visit https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/novartis-issues-voluntary-nationwide-recall-promactar-125-mg-oral-suspension-due-potential-peanut for more information.